Xu, Jing <br/><br/>
The PPARγ agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthma.  [electronic resource] 

 -  Acta pharmacologica Sinica  Feb 2015 
 - 171-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1745-7254 
<br/><br/><label>Standard No.: </label>10.1038/aps.2014.128  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Asthma--drug therapy<br/>Disease Models, Animal<br/>Female<br/>Heme Oxygenase-1--metabolism<br/>Inflammation--drug therapy<br/>Lung--drug effects<br/>Membrane Proteins--metabolism<br/>Mice<br/>Mice, Inbred BALB C<br/>PPAR gamma--agonists<br/>Rosiglitazone<br/>Thiazolidinediones--pharmacology